Clinical Associate Professor in Hepatology, Faculty of Medicine & Health Sciences
Dr Neil Guha is a Clinical Associate Professor in Hepatology at the University of Nottingham. He trained at Guy's and St. Thomas's hospitals and began his postgraduate career in hepatology at St. Mary's Hospital, London. His doctoral thesis, awarded by the University of Southampton, focussed on non-invasive biomarkers of liver fibrosis. He completed his clinical training at the Southampton Liver Unit and was appointed as a clinical lecturer by the University of Southampton in 2008. He moved to Nottingham in 2009 to commence his current post at the National Institute of Health Research Nottingham Digestive Diseases Centre Biomedical Research Unit. His research continues to focus on biomarkers of liver fibrosis with current work in serum markers, hypothesis generating technologies, imaging modalities and utilisation of biomarkers in clinical practice.
Non-invasive assessment of liver fibrosis
Experimental diagnostics of chronic liver injury
Clinical application of liver biomarkers
Novel MRI imaging techniques in chronic liver… read more
GUHA, I.N., PARKES, J., RODERICK, P., CHATTOPADHYAY, D., CROSS, R., HARRIS, S., KAYE, P., BURT, A.D., RYDER, S.D., AITHAL, G.P., DAY, C.P. and ROSENBERG, W.M., 2008. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers Hepatology: Official Journal of the American Association of the Study of Liver Diseases. 47(2), 455-460 TANWAR, S., TREMBLING, P.M., GUHA, I.N., PARKES, J., KAYE, P., BURT, A.D., RYDER, S.D., AITHAL, G.P., DAY, C.P. and ROSENBERG, W.M., 2013. Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease Hepatology. 57(1), 103-111
PRITCHETT, J., HARVEY, E., ATHWAL, V., BERRY, A., ROWE, C., OAKLEY, F., MOLES, A., MANN, D.A., BOBOLA, N., SHARROCKS, A.D., THOMSON, B.J., ZAITOUN, A.M., IRVING. W.L., GUHA, I.N., HANLEY, N.A. and HANLEY, K.P., 2012. Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans Hepatology. 56(3), 1108-1116